Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
NASA will slam a multimillion-dollar spacecraft into an asteroid to test whether it is possible to change a space rock’s trajectory. Plus, childhood colds might change how the immune system responds to COVID.
The “Esperanza Patient” was diagnosed with HIV in 2013, but has never shown any symptoms of AIDS. Plus, the first stable hot black ice and how COVID-19 has affected mental health.
Sometimes atoms’ size, not electronegativity, determine the strengths of chemical bonds. Plus, the unsung scientist who identified cystic fibrosis, and the start-ups chasing fusion energy.
How some fish can live for more than 200 years, the questions swirling around new Alzheimer’s drugs and how one of the world’s last COVID-elimination strategies is panning out in China.
‘Davemaoite’ usually only exists in the deep Earth. Plus, homicide is a top cause of maternal death in the United States, and what scientists think of the Glasgow Climate Pact.
How some people’s immune cells might ‘abort’ SARS-CoV-2 infection. Plus, an expanding molecular toolbox to probe neural circuits and your COP26 questions answered.
The two biggest greenhouse-gas emitters have issued a surprise joint declaration at COP26. Plus, how Merck and Pfizer’s antiviral pills might reshape the pandemic, and the origin story of the arXiv.
Promising news for the treatment of serious depression with psilocybin. Plus, how protein-based COVID vaccines could change the pandemic and NASA delays its Moon landing mission to 2025.
“We dared to ask: what if we just give everything away?” Plus, scammers impersonate guest editors to get sham papers published, and the world’s climate pledges might be built on flawed data.
Pfizer antiviral cut the risk of hospitalization or death by 89% for vulnerable people newly diagnosed with COVID-19. Plus, what sponges can tell us about the nervous system, and scientists judge the COP pledges so far.
Carbon emissions have rebounded after COVID shutdowns, but a reassessment of croplands offers hints of hope. Plus, breakthroughs and bombast from the first week of COP26.
How whaling devastated a once-rich undersea ecosystem — and how to restore the cycle. Plus, evidence for when masks are most useful against COVID-19, and the super-ambitious ten-year plan for US astronomy.
Indonesia has given the Novavax COVID-19 vaccine its first emergency use authorization. Plus, lessons from the UK’s COVID strategy, and the banks’ plan to help get us to net zero.
As the COP26 climate conference kicks off, Nature explains what success looks like, and what’s on the line. Plus, we explore the nuclear legacy of Abdul Qadeer Khan and learn that honey bees ‘social distance’ to fight mites.
The inexpensive antidepressant fluvoxamine cuts the risk of death among high-risk COVID-19 patients. Plus: the search for people who are genetically resistant to SARS-CoV-2 infection, and the effects of civil war on bird life.
Despite searching for decades, researchers still haven’t found any signs that the hypothetical particles exist. Plus: predatory publishers’ latest scam, and how vaccinating young kids could affect the pandemic.
Ancient DNA has allowed researchers to trace the origins of 4,000-year-old mummies in China. Plus: Bacteria imaged in unprecedented detail, and plans for Africa’s first synchrotron.
Astronomers have found hints of what could be the first planet ever discovered outside our galaxy. Plus: A scientists’ guide to COP26, and a strikingly detailed look at the insides of cells.